Literature DB >> 479638

Immune responses of humans to a human diploid cell strain of rabies virus vaccine: lymphocyte transformation, production of virus-neutralizing antibody, and induction of interferon.

K G Nicholson, P J Cole, G S Turner, P Harrison.   

Abstract

Lymphocyte transformation, production of neutralizing antibody, and interferon activity of 20 healthy volunteers in response to a human diploid cell strain (HDCS) of rabies virus vaccine were studied. Ten vaccines received 1.0 ml of HDCS vaccine on days 0, 3, 7, and 14, and five of these volunteers received, in addition, 20 international units of human rabies immune globulin/kg of body weight on day 0. All 10 volunteers developed high titers of neutralizing antibody, and eight of the 10 had lymphocytes that were immunologically stimulated by HDCS rabies virus antigen. The interferon responses of eight vaccines to 1.0 ml of HDCS vaccine given intramuscularly on days 0 and 28 and of two vaccines to 1.0 ml of vaccine given intradermally in eight body sites on the same days were measured; low levels of interferon-like activity were found in eight of nine volunteers after the first vaccination, and no activity was found upon revaccination. The high titers of neutralizing antibody that developed did not correlate with lymphocyte stimulation or interferon-like activity, but it is true that all 20 volunteers did develop high titers of neutralizing antibody after 1.0 ml of HDCS vaccine was given intradermally.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 479638     DOI: 10.1093/infdis/140.2.176

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  8 in total

1.  Evaluation of a human diploid cell strain rabies vaccine: final report of a three year study of pre-exposure immunization.

Authors:  G S Turner; K G Nicholson; D A Tyrrell; F Y Aoki
Journal:  J Hyg (Lond)       Date:  1982-08

2.  BCG modulation of delayed type hypersensitivity, humoral response and acquired resistance after rabies vaccination.

Authors:  H Tsiang; J Blancou; P H Lagrange
Journal:  Arch Virol       Date:  1981       Impact factor: 2.574

3.  Multisite intradermal antirabies vaccination. Immune responses in man and protection of rabbits against death from street virus by postexposure administration of human diploid-cell-strain rabies vaccine.

Authors:  K G Nicholson; H Prestage; P J Cole; G S Turner; S P Bauer
Journal:  Lancet       Date:  1981-10-24       Impact factor: 79.321

4.  Purified chick embryo cell rabies vaccine: economical multisite intradermal regimen for post-exposure prophylaxis.

Authors:  P Suntharasamai; M J Warrell; C Viravan; P Chanthavanich; S Looareesuwan; A Supapochana; J K Supanaranond; S Chittamas; U Bijok; D A Warrell
Journal:  Epidemiol Infect       Date:  1987-12       Impact factor: 2.451

5.  T and B cell human responses to European bat lyssavirus after post-exposure rabies vaccination.

Authors:  M Herzog; C Fritzell; M Lafage; J A Montaño Hirose; D Scott-Algara; M Lafon
Journal:  Clin Exp Immunol       Date:  1991-08       Impact factor: 4.330

6.  High rate of insufficient antibody titers after single-day immunization with human diploid-cell-strain vaccine against rabies.

Authors:  M G Täuber; R Putzi; P Fuchs; R Wyler; R Lüthy
Journal:  Klin Wochenschr       Date:  1986-06-02

7.  Vaccination with rabies to study the humoral and cellular immune response to a T-cell dependent neoantigen in man.

Authors:  D M C Brinkman; C M Jol-van der Zijde; M M ten Dam; J M Vossen; A D M E Osterhaus; F P Kroon; M J D van Tol
Journal:  J Clin Immunol       Date:  2003-11       Impact factor: 8.542

Review 8.  [New aspects of rabies control].

Authors:  H Bourhy; G D de Melo; A Tarantola
Journal:  Bull Acad Natl Med       Date:  2020-09-18       Impact factor: 0.144

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.